Cyclacel Pharmaceuticals (CYCC) Stock: Heading Up On Data Presentation

Cyclacel Pharmaceuticals CYCC Stock News

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) is trading in the green early this morning, and for good reason. The company announced the presentation of positive data, exciting investors who are pushing the stock up. Today, we’ll talk about: The data; what we’re seeing from CYCC stock as a result; and what we’ll be watching for ahead. … Read more

Cyclacel Pharmaceuticals (CYCC) Stock: Gaining Big On Publication Validating CYC065

Cyclacel Pharmaceuticals CYCC Stock News

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced the publication of findings surrounding Cyclin E1 that further validates its work with its CYC065 treatment. Today, we’ll talk about: The publication; what we’re seeing from CYCC stock as a result; … Read more

Cyclacel Pharmaceuticals (CYCC) Stock: Gaining Big On Patent News

Cyclacel Pharmaceuticals IncĀ (NASDAQ: CYCC) is having an overwhelmingly strong day in the market today, and for good reason. The company announced that it has been granted a new patent, adding to the protection of its intellectual property. Today, we’ll talk about the patent, what we’re seeing from the stock, and what we’ll be watching for … Read more

Cyclacel Pharmaceuticals (CYCC) Stock: Gains Big On Positive Clinical Data

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) Cyclacel Pharmaceuticals is having an incredibly strong startĀ to the trading session today. At the opening bell, the stock was trading well into the green. While it did dip for a short while, it quickly made up the gains. So quick, in fact, that it was halted, prompting our partners at … Read more

Cyclacel Pharmaceuticals (CYCC) Stock Climbs On Phase 1 Data

Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) Cyclacel Pharmaceuticals is having an incredible day in the market today, and for good reason. Early this morning, the company reported Phase 1 data surrounding one of its lead candidates, and that data was overwhelmingly positive. Today, we’ll talk about what we saw, how the market reacted to the news, … Read more